Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Myrtoid and 2% diltiazem versus placebo in chronic anal fissure complications
IRCT20160914029818N3Phase 3Completed
- Sponsor
- Baqiyatallah University of Medical Sciences
- Start
- Apr 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of diltiazem in chronic anal fissure (CAF) (3 arms), sponsored by Baqiyatallah University of Medical Sciences. Started Apr 2017; status: completed.
02
Drugs
diltiazem
03
Conditions
chronic anal fissure (CAF)
Beyond the preview
Go deeper on IRCT20160914029818N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20160914029818N3.